In the attached report average Valuation for Phase 3 biotech companies on the asx is $405 mill and Phase 2 are valued at $80 mill ,go to page 34 to see the table .We have 3 Phase 2 possibilities .Possible Valuation $645 mill and we are currently valued on the asx at $150 mill .The current valuation is certainly out of whack .
https://www2.asx.com.au/content/dam/asx/documents/listings/AusBiotech-Guide-to-Life-Sciences-Investing-web-version.pdf
- Forums
- ASX - By Stock
- NEU
- Valuations
Valuations
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.25 |
Change
0.430(2.17%) |
Mkt cap ! $2.585B |
Open | High | Low | Value | Volume |
$19.89 | $20.39 | $19.77 | $5.715M | 283.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 355 | $20.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.29 | 302 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 248 | 20.200 |
1 | 845 | 20.160 |
1 | 2308 | 20.140 |
3 | 1963 | 20.130 |
1 | 951 | 20.110 |
Price($) | Vol. | No. |
---|---|---|
20.320 | 1118 | 2 |
20.330 | 845 | 1 |
20.350 | 3000 | 1 |
20.360 | 845 | 1 |
20.390 | 845 | 1 |
Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$20.22 |
  |
Change
0.430 ( 2.40 %) |
|||
Open | High | Low | Volume | ||
$19.86 | $20.40 | $19.77 | 85257 | ||
Last updated 15.59pm 07/05/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online